Replies to post #194883 on Biotech Values

[lgonber]

I thought they were not going to present data at the Lung conference and Was expecting the data of 40% response rate or more by end of the year

[DewDiligence]

MRTX sells 2.59M* shares @$45.00—a 3% discount to Monday’s closing price:

http://finance.yahoo.com/news/mirati-therapeutics-announces-pricing-public-003500811.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

MRTX -41% on need for Glesatinib reformulation:

http://finance.yahoo.com/news/mirati-therapeutics-provides-progress-current-130000049.html